Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant

Intranasal Immunization of Mice with Inactivated Virus and Mast Cell Activator C48/80 Elicits Protective Immunity against Influenza H1 but not H5

(2013) Lili Xu et al.   IMMUNOLOGICAL INVESTIGATIONS

Development of universal influenza vaccines based on influenza virus M and NP genes

(2013) M. Zheng et al.   INFECTION

Contributions of Antinucleoprotein IgG to Heterosubtypic Immunity against Influenza Virus

(2011) Mark W. LaMere et al.   JOURNAL OF IMMUNOLOGY

Intranasal Immunization with Recombinant HA and Mast Cell Activator C48/80 Elicits Protective Immunity against 2009 Pandemic H1N1 Influenza in Mice

(2011) Shu Meng et al.   PLoS One

Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein

(2010) Lina Guo et al.   ARCHIVES OF VIROLOGY

Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant

(2010) Zhiwei Sui et al.   VACCINE

A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice

(2009) Liyun Zheng et al.   BMC INFECTIOUS DISEASES

Pandemic preparedness: Toward a universal influenza vaccine

(2009) K. Roose et al.   DRUG NEWS & PERSPECTIVES

Single-chain intracellular antibodies inhibit influenza virus replication by disrupting interaction of proteins involved in viral replication and transcription

(2008) Muhammad Mahmood Mukhtar et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Mast cell activators: a new class of highly effective vaccine adjuvants

(2008) James B McLachlan et al.   NATURE MEDICINE

Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus

(2008) Quanjiao Chen et al.   VIRUS GENES